Muscular Dystrophy Advanced Evaluation

Test Code

901618

CPT Codes
81161, 81404 (x4), 81405 (x9), 81406 (x7), 81408 (x2), 81479<br /> Limited Access Code

Preferred Specimen

8 mL whole blood collected in EDTA (lavender-top) tubes, or
Pediatric 0-3 years: 2 mL whole blood

Minimum Volume

6 mL • 1 mL pediatric whole blood

Instructions

Overnight shipping preferred

Transport Temperature

Room temperature

Specimen Stability

Room temperature: 10 days
Refrigerated: 10 days
Frozen: Unacceptable

Methodology
Next Generation Sequencing

FDA Status
This test was developed and its analytical performance characteristics have been determined by Athena Diagnostics. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule

Set up: Varies; Report available: 21-28 days

Reference Range

See Laboratory Report

Clinical Significance

Tests for sequence variations in 33 genes, including duplications/deletions in 4 of these genes that are associated with muscle weakness and wasting of variable and heterogeneous severity, age of onset, rate of progression, mode of inheritance, and complications.

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.